General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Implied Volatility Surging for Axsome Therapeutics (AXSM) Stock Options | news.google.com • |
Implied Volatility Surging for Axsome Therapeutics (AXSM) Stock Options | news.google.com • |
The 3 Most Undervalued Biotech Stocks to Buy in May 2024 | investorplace.com • |
Prediction: These 2 Growth Stocks Could Triple By 2030 | fool.com • |
Axsome Therapeutics to Present at Upcoming Investor Conferences | globenewswire.com • |
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates | zacks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-06 | 2024-03 | -1.2 | -1.09 | 0.11 | 9.17% |
2024-02-20 | 2023-12 | -1.21 | -0.73 | 0.48 | 39.67% |
2023-11-06 | 2023-09 | -1.24 | -1.32 | -0.08 | -6.45% |
2023-08-07 | 2023-06 | -1.24 | -1 | 0.24 | 19.35% |
2023-05-08 | 2023-03 | -1.13 | -0.22 | 0.91 | 80.53% |
2023-02-27 | 2022-12 | -1.18 | -1.28 | -0.1 | -8.47% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-24 | Mizuho | Upgrade | Buy | Buy |
2023-08-27 | Mizuho | Upgrade | Buy | Buy |
2023-08-21 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-10 | Mizuho | Upgrade | Buy | Buy |
2023-08-07 | B of A Securities | Upgrade | Underperform | Neutral |
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-09-14 | COLEMAN MARK H | Director | 0.00 | Sale |
2024-03-31 | JACOBSON MARK L | Chief Operating Officer | 0.00 | Sale |
2024-03-14 | JEFFS ROGER A | Director | 167.67K | Sale |
2015-12-22 | KAYE RANDALL E | Officer | 0.00 | Purchase |
2021-11-17 | PIZZIE NICK | Chief Financial Officer | 0.00 | Purchase |
2021-11-16 | SAAD MARK E | Director | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | RTW Investments LP | 4.28M | 307.87M | 9.08% |
2023-06-29 | Vanguard Group Inc | 3.74M | 268.95M | 7.93% |
2023-06-29 | Blackrock Inc. | 2.72M | 195.71M | 5.77% |
2023-06-29 | Fairmount Funds Management LLC | 2.34M | 168.51M | 4.97% |
2023-06-29 | BVF Inc. | 2.13M | 153.14M | 4.52% |
2023-06-29 | FMR, LLC | 2.13M | 152.99M | 4.51% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.16M | 83.49M | 2.46% |
2023-06-29 | Vanguard Small-Cap Index Fund | 961.88K | 69.12M | 2.04% |
2023-08-30 | iShares Russell 2000 ETF | 749.42K | 60.55M | 1.59% |
2023-06-29 | Vanguard Small Cap Value Index Fund | 666.33K | 47.88M | 1.41% |
2023-06-29 | Vanguard Extended Market Index Fund | 474.15K | 34.07M | 1.00% |
2023-07-30 | Fidelity Small Cap Growth Fund | 303.66K | 23.83M | 0.64% |
$AXSM BRING PROFITS TO $TNON ITS GOING TO SOAR! Went up 350% yesterday and has SO much more room to run looking at the RSI levels and the charts! It’s only down -2% today for consolidation! Now analysts expect it to BURST by 3pm or after hours max! Little volume will send it to the moon but no one knows about it! Thank me later! $TNON
The corresponding volume doesn't support this price movement (IMO). I fear an impending rug-pull...
It’s a explainable to be up near $35 pre-market to now have this result.
This stock is truly becoming a stagnant piece of .
The share volume feels light compared to todays price jump.
This constant “news, news, news” in this room is so tired and downright annoying.
Oh look, all gains forfeited right on target…
Yet again this stock loses its gains, and more. Pretty certain since seeing 42+ this stock hasn’t seen a green day. Meanwhile, those of us investing thousands on thousands can’t get even a small semblance of an update on FDA efforts, or anything for that matter.
New day, same effing song and dance. We can't sniff above $42 for more than a day since seeing $43 AH.
Its becoming clear, sell AXSM at opening, buy back and noon, rinse and repeat…mine as well share in laundry cycles of everyone else in this stock…
Yes we going up come to AXSM